Trials / Completed
CompletedNCT04206163
Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis
Somatostatin Receptor Imaging in Inflammatory Heart Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Vastra Gotaland Region · Other Government
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This prospective imaging study investigates the diagnostic ability of Gallium-68 DOTA-TOC (68Ga-DOTA-TOC) positron emission tomography/computed tomography (PET/CT) in the clinical work-up of patients with 1) clinically suspected acute myocarditis (n=30-40) and 2) clinically suspected cardiac sarcoidosis (n=30-40) using clinical diagnostic criteria as well as endomyocardial biopsy as reference. Furthermore, 68Ga-DOTA-TOC PET/CT findings will be compared with results from contrast-enhanced magnetic resonance imaging (MRI) and in case of cardiac sarcoidosis even Fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT, which are both performed as part of the clinical routine work-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 68Ga-DOTA-TOC PET/CT | Somatostatin receptor imaging |
| BIOLOGICAL | Blood sample | Analysis of inflammatory biomarkers |
Timeline
- Start date
- 2020-01-20
- Primary completion
- 2024-06-24
- Completion
- 2024-06-24
- First posted
- 2019-12-20
- Last updated
- 2024-09-27
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04206163. Inclusion in this directory is not an endorsement.